When the next occupant of the White House moves in and the 435 House and 100 Senate members start the 119th session of Congress in January, on their plates will be a regulatory question plaguing lawmakers and executive agencies since 2019.
Whether Democrat Kamala Harris or Republican Donald Trump is in the White House or which party has a majority in either or both chambers of Congress, the Food and Drug...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?